SCHEMBL2983443

SCHEMBL2983443

COC(=O)C(C)(C)OCc1ccc(C=CCO)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.45
CYP4A11 Q02928 1/20 0.45
PPARG P37231 2/20 0.40
PPARA Q07869 2/20 0.40
HDAC3 O15379 7/20 0.36
HDAC1 Q13547 7/20 0.36
HDAC2 Q92769 7/20 0.36
HDAC8 Q9BY41 7/20 0.36
HDAC4 P56524 6/20 0.36
HDAC7 Q8WUI4 6/20 0.36
HDAC10 Q969S8 6/20 0.36
HDAC11 Q96DB2 6/20 0.36
HDAC6 Q9UBN7 6/20 0.36
HDAC9 Q9UKV0 6/20 0.36
HDAC5 Q9UQL6 6/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
TYR P14679 1/20 0.36
CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2983440 1.00 CYP4F2 (0.45) CYP4F2CYP4A11PPARGPPARAHDAC3
SCHEMBL2983792 0.88 CYP4F2 (0.44) CYP4F2CYP4A11PPARGPPARAHDAC3
SCHEMBL2983790 0.88 CYP4F2 (0.44) CYP4F2CYP4A11PPARGPPARAHDAC3
SCHEMBL13078234 0.81 PPARG (0.47) CYP4F2CYP4A11PPARGPPARATP53
SCHEMBL2716903 0.76 CYP3A4 (0.44) CYP3A4
SCHEMBL13994548 0.76 KMT2A (0.50) ALDH1A1LMNA
SCHEMBL3511047 0.76 HTT (0.53) ALDH1A1
SCHEMBL10349973 0.76 MEN1 (0.49) ALDH1A1LMNA
SCHEMBL2982136 0.75 CYP4A11 (0.54) CYP4F2CYP4A11PPARACA2
SCHEMBL2719920 0.73 PPARG (0.52) PPARGPPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100286144-A1 HETEROARYL DERIVATIVES TAKAHASHI YOKO 2010-11-11 US disclosed
US-7781479-B2 Heteroaryl derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2010-08-24 US disclosed
US-20080167306-A1 Novel Heteroaryl Derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-07-10 US disclosed
EP-1837329-A1 NOVEL HETEROARYL DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2007-09-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100286144-A1 HETEROARYL DERIVATIVES GPR119, SLC2A1, SLC2A4 CYP4F2 349/4885CYP4A11 46/4885PPARG 430/4885
US-20080167306-A1 Novel Heteroaryl Derivative GPR119, SLC2A4, SLC5A2 CYP4F2 288/4885CYP4A11 37/4885PPARG 498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.